Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Following the hedgehog to new cancer therapies.

Dlugosz AA, Talpaz M.

N Engl J Med. 2009 Sep 17;361(12):1202-5. doi: 10.1056/NEJMe0906092. Epub 2009 Sep 2. No abstract available.

PMID:
19726764
2.

Hedgehog signaling in basal cell carcinoma.

Otsuka A, Levesque MP, Dummer R, Kabashima K.

J Dermatol Sci. 2015 May;78(2):95-100. doi: 10.1016/j.jdermsci.2015.02.007. Epub 2015 Feb 23. Review.

PMID:
25766766
3.

Clinical implications of hedgehog signaling pathway inhibitors.

Liu H, Gu D, Xie J.

Chin J Cancer. 2011 Jan;30(1):13-26. Review.

4.

Basal cell carcinomas: attack of the hedgehog.

Epstein EH.

Nat Rev Cancer. 2008 Oct;8(10):743-54. doi: 10.1038/nrc2503. Review.

5.

[Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].

Watson S, Serrate C, Vignot S.

Bull Cancer. 2010 Dec;97(12):1477-83. doi: 10.1684/bdc.2010.1231. Review. French.

6.

Basal cell carcinoma: hedgehog pathway inhibitors and beyond.

Walls B.

Cutis. 2013 Jun;91(6):E1-4. Review. No abstract available.

PMID:
23837158
7.

[Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].

Wolodarski M, Lapins J, Hansson J.

Lakartidningen. 2013 Apr 24-May 6;110(17-18):886-8. Review. Swedish. No abstract available.

PMID:
23717940
8.

Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond.

Mohan SV, Chang AL.

Semin Cutan Med Surg. 2014 Jun;33(2):68-71. Review.

PMID:
25085664
9.

Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.

Tang JY.

Semin Cutan Med Surg. 2011 Dec;30(4 Suppl):S6-9. doi: 10.1016/j.sder.2011.11.001. Review.

PMID:
22177103
10.

Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists.

Metcalfe C, de Sauvage FJ.

Cancer Res. 2011 Aug 1;71(15):5057-61. doi: 10.1158/0008-5472.CAN-11-0923. Epub 2011 Jul 19. Review. Erratum in: Cancer Res. 2011 Sep 15;71(18):6087.

11.

Emerging treatments and signaling pathway inhibitors.

Tang JY, Marghoob AA.

Semin Cutan Med Surg. 2011 Dec;30(4 Suppl):S14-8. doi: 10.1016/j.sder.2011.11.002. Review.

PMID:
22177102
12.

Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.

Sekulic A, Mangold AR, Northfelt DW, LoRusso PM.

Curr Opin Oncol. 2013 May;25(3):218-23. doi: 10.1097/CCO.0b013e32835ff438. Review.

PMID:
23493193
13.

Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.

Sobanko JF, Okman J, Miller C.

J Drugs Dermatol. 2013 Oct;12(10 Suppl):s154-5. Review.

PMID:
24085062
14.

Vismodegib.

Meiss F, Zeiser R.

Recent Results Cancer Res. 2014;201:405-17. doi: 10.1007/978-3-642-54490-3_25. Review.

PMID:
24756807
15.

Targeting the hedgehog pathway to treat basal cell carcinoma.

Geeraert P, Williams JS, Brownell I.

J Drugs Dermatol. 2013 May;12(5):519-23. Review.

PMID:
23652945
16.

Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.

Proctor AE, Thompson LA, O'Bryant CL.

Ann Pharmacother. 2014 Jan;48(1):99-106. doi: 10.1177/1060028013506696. Epub 2013 Oct 15. Review.

PMID:
24259609
17.

Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.

Cirrone F, Harris CS.

Clin Ther. 2012 Oct;34(10):2039-50. doi: 10.1016/j.clinthera.2012.08.011. Epub 2012 Oct 1. Review.

PMID:
23036338
18.

The role of hedgehog signalling in tumorigenesis.

Wicking C, McGlinn E.

Cancer Lett. 2001 Nov 8;173(1):1-7. Review.

PMID:
11578802
19.

Understanding BCC pathogenesis: treatment advancements and challenges.

Goldenberg G, Hamid O.

J Drugs Dermatol. 2013 Oct;12(10):1110-20. Review. No abstract available.

PMID:
24085046
20.

Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.

Lupi O.

Int J Dermatol. 2007 Nov;46(11):1113-7. Review.

PMID:
17988327

Supplemental Content

Support Center